The possible involvement of a GTP-binding protein in the regulation of Ca2' channels by angiotensin II (Ang II) in vascular muscle cells was investigated by the whole-cell voltage-clamp method. Single cells were freshly isolated from guinea pig portal vein. The pipette solution contained high Cs4 to inhibit K4 currents and thereby isolate the Ca2+ channel current. Ba24 (2 mM) was in the bath solution as a charge carrier for the Ca24 channel. Application of Ang II (0.1-100 nM) produced an increase in peak amplitude of the Ba24 current, with a shift of the current-voltage curve in the negative direction. These effects were inhibited by pretreatment with an antagonist of the Ang II receptor, [Sar',lle8]-Ang II. Presence of 0.1 mM GTP in the pipette solution stabilized the Ang II action, but 0.3-1.0 mM GDP-,B-S and 1.0 mM GTP-y-S inhibited it. GTP-y-S alone produced a slowly progressing increase in the basal (unstimulated) current amplitude. Preincubation of muscle tissues with pertussis toxin (1 ,g/ml, for up to 6 hours at 36°C) or intracellular application of preactivated pertussis toxin (1 ,ug/ml) plus NAD (1 mM) did not inhibit the Ang II action. Cholera toxin (10 ,ug/ml) also had no effect on the Ang LI action. These results suggest that the Ang II stimulation of Ca24 channels in smooth muscle of guinea pig portal vein may be mediated by a G protein that is insensitive to both pertussis toxin and cholera toxin. (Circulation Research 1991;68:763-771) R elatively little is known about mechanisms of action of various hormones on Ca2' slow channels in vascular smooth muscle cells. Several recent studies showed that some hormones, such as norepinephrine and angiotensin II (Ang II), enhanced the activation of voltagedependent Ca2' channels.1-3 This action is considered to be one of the mechanisms for the contraction induced by these agonists. However, other reports suggested that these agonists actually inhibited the calcium channels.4 Therefore, there is controversy concerning the mechanism of the hormonal modulation of the Ca2' channels, and the agonists may act by more than one mechanism (multifactor).
Presence of 0.1 mM GTP in the pipette solution stabilized the Ang II action, but 0.3-1.0 mM GDP-,B-S and 1.0 mM GTP-y-S inhibited it. GTP-y-S alone produced a slowly progressing increase in the basal (unstimulated) current amplitude. Preincubation of muscle tissues with pertussis toxin (1 ,g/ml, for up to 6 hours at 36°C) or intracellular application of preactivated pertussis toxin (1 ,ug/ml) plus NAD (1 mM) did not inhibit the Ang II action. Cholera toxin (10 ,ug/ml) also had no effect on the Ang LI action. These results suggest that the Ang II slow channels in vascular smooth muscle cells. Several recent studies showed that some hormones, such as norepinephrine and angiotensin II (Ang II), enhanced the activation of voltagedependent Ca2' channels.1-3 This action is considered to be one of the mechanisms for the contraction induced by these agonists. However, other reports suggested that these agonists actually inhibited the calcium channels.4 Therefore, there is controversy concerning the mechanism of the hormonal modulation of the Ca2' channels, and the agonists may act by more than one mechanism (multifactor).
Ang II is a potent vasoconstrictor, and application of this hormone depolarized and triggered action free solution, the enhancement of the calcium channel current by Ang II was observed more consistently than when they were stored in a Ca'+-containing solution.
Noncontracted cells were spindle-shaped (length, 100-200 Atm; diameter, 3-8 ,um (20-22°C) .
To record the Ca'2 channel current, test command potentials were applied every 10 seconds from a holding potential of -90 mV. The maximal peak amplitudes of the Ca'+ channel currents were less than 500 pA (usually 100-300 pA), and the input resistance of the cell was more than 5 GQ. Series resistance was partly compensated electrically, usually 60-80%. Leak and residual capacitive currents were subtracted using the currents elicited by small hyperpolarizing or depolarizing pulses. The background noise was reduced by signal averaging. The liquid junction potential between the pipette and bath solution was corrected (approximately 10 The dose-response relation of the Ang II action on peak amplitudes of the calcium channel currents is plotted in Figure 3 ( (Figure 3 , filled circles).
The effects of intracellular GTP-y-S were examined; GTP-y-S was dialyzed into the cell for either 1-3 or 5-8 minutes. As a control, the effect of Ang II was examined using GTP Figure 1 . Figure 4A b, a 7-minute incubation with 1 mM GTP-y-S inhibited the Ang II action. A summary of the changes in the current amplitudes during GTP-y-S incubation and Ang II application is plotted in Figure 4B , Figure 4C . Figure 5A ). 
. (5(3) . Effects of Ang II on the calcium channel current under different conditions (with 0.1 mM GTP or with 0.3 and 1 mM GDP-,B-S) are plotted in Figure 5B . This figure shows that higher concentration and longer incubation with GDP-13-S inhibited the effect of Ang II.
In an attempt to further clarify the involvement of GTP-binding protein, the bacterial toxins PT and CT were used, as described in "Materials and Methods." Toxin treatments did not produce significant change in the averaged amplitude of the basal current (unstimulated): 1) PT preincubation: control, 138 In the present study, we did not distinguish between the slow (L-type, high-threshold) and fast (T-type, low-threshold) calcium channel currents, '17 B3. because changing holding potential failed to separate the basal current into two components in unstimulated conditions (data not shown). Furthermore, the shape of current traces at the lower command potential had almost no decay, indicating there was only little fast current in unstimulated conditions ( Figure  1 ). After application of Ang II, the current-voltage curve was shifted in the negative direction, and decay of the current was slightly accelerated. These changes suggest that the fast Ca2' current appeared after stimulation by Ang II. However, the current amplitudes measured at the peak and at the end of the pulse (200 msec) were enhanced equally by Ang II. This argues against the predominant enhance- ment of the fast current. Another possibility is that the shift of the current-voltage curve and the change in current decays may be due to a kinetic change of the slow Ca'4 channels.
The action of Ang II was time dependent. After application of Ang II, the current at first increased and then decayed slowly. Higher concentrations of Ang II provoked faster increase and faster decay. Two possible mechanisms may be considered to explain the transient action: 1) only an excitatory mechanism exists, and it works transiently, or 2) at least two mechanisms (excitatory and inhibitory) are provoked by Ang II. A similar time-dependent action of Ang II was seen in force recording and in the calcium transient (using fura 2).15 It was thought that this transient action was closely related to a tachyphylaxis usually observed in the Ang II response in vascular tissues. 16 The analogues of GTP, GDP-(3-S and GTP-y-S, are considered to be good tools to examine the involvement of G protein in the receptor coupling with various effectors, including gating of ion channels by G proteins.18 GTP-y-S is thought to 1) substitute for endogenous GTP at the binding site of the G protein, 2) be a poor substrate for GTPase, causing a persistent effect, and 3) cause slowly increasing activation of G protein in the absence of agonist stimulation.18 In electrophysiological studies, a persistent and strong effect of GTP-y-S was observed in the activation of the GK channel in atrial cells and in the inhibition of the calcium currents of neuronal cells. [19] [20] [21] In the present study, GTP-y-S induced a slowly progressive increase in the basal current amplitude and consequently inhibited the subsequent Ang II action. The progressive increase in the current amplitude might be due to the slow increase in degree of activation of G protein. Thus, the usual stimulatory effect of Ang II on the Ca'+ channels would be inhibited.
If GTP-binding protein is involved, the effect induced in the presence of GTP-y-S would be irreversible. However, in the present experiments, the effect induced by Ang II in the presence of GTP-y-S was transient. This also may indicate the presence of a secondary inhibitory effect produced by Ang It was reported in guinea pig ventricular cells25 that application of an inhibitor for cyclic AMP-dependent phosphorylation did not suppress the basal current but only inhibited the action of ,B-agonists.
This suggested that basal activity of the Ca'2 channels in ventricular cells may be independent of cyclic AMP-dependent phosphorylation of the channel protein.
High concentration and long incubation of the GTP analogues were needed to inhibit the Ang II action on the Ca'2 channels, and the inhibition was not complete. Also, the GTP-y-S-induced enhancement was not as large as the Ang Il-induced enhancement, although GTP-y-S should produce a strong enhancement of the calcium channel current. Perhaps substitution by a GTP analogue takes time in the whole-cell patch configuration,21 or contamination of other chemicals in the GTP-y-S (and GDP-,B-S) may interfere, as suggested.'9,21'26 Furthermore, the low temperature (22°C) used in the present experiments might be another possible reason for the weak action of the GTP analogue.
PT is a bacterial toxin that ribosylates the subunit of Gi or Gi-like protein, and consequently inhibits the action of G protein (see Reference 27) 
